fig1
![Why nanodiamond carriers manage to overcome drug resistance in cancer](https://image.oaes.cc/5eba220f-67d5-4f47-be3e-11a1e7827155/3691.fig.1.jpg)
Figure 1. Fate and basic interactions of nanodiamonds after their intravenous administration. The differences between shielded vs. unshielded and small vs. large nanoparticles are shown. ND: nanodiamond
Figure 1. Fate and basic interactions of nanodiamonds after their intravenous administration. The differences between shielded vs. unshielded and small vs. large nanoparticles are shown. ND: nanodiamond
All published articles will preserved here permanently:
https://www.portico.org/publishers/oae/